Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain
| Autor: | Miguel de Mulder, Miguel Ángel Roa, JT Ramos, José Beceiro, Daniel Blázquez, Gonzalo Yebra, Adriana Navas, L. Prieto, María José Mellado, María Isabel González-Tomé, Pablo Rojo, Luis Prieto, I. Gonzalez-Granados, María Dolores Gurbindo, M L Navarro, Mellado Mj, Jesús Saavedra-Lozano, Santiago Jiménez de Ory, S Guillén, Rafael Delgado, María Ángeles Muñoz-Fernández, Leticia Martín, África Holguín, P. Rojo, M.I. de José, José Luis Martínez, Pablo Martin-Fontelos, José Tomás Ramos |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
Microbiology (medical) Pediatrics medicine.medical_specialty Adolescent Anti-HIV Agents Molecular Sequence Data Human immunodeficiency virus (HIV) HIV Infections Drug resistance medicine.disease_cause Cohort Studies Viral genetics Antiretroviral Therapy Highly Active Drug Resistance Viral medicine Humans Protease Inhibitors Pharmacology (medical) Base sequence Child Phylogeny Pharmacology Acquired Immunodeficiency Syndrome Base Sequence business.industry Infant Sequence Analysis DNA Antiretroviral therapy Infectious Diseases Spain pol Gene Products Human Immunodeficiency Virus Child Preschool Mutation Cohort HIV-1 Reverse Transcriptase Inhibitors Female business Paediatric population Cohort study |
| Zdroj: | Journal of Antimicrobial Chemotherapy. 66:2362-2371 |
| ISSN: | 1460-2091 0305-7453 |
| DOI: | 10.1093/jac/dkr305 |
| Popis: | Drug resistance mutations affect antiretroviral therapy (ART) effectiveness in HIV-1-infected children, compromising long-term therapy. HIV-1 variants and drug resistance mutations were identified in HIV-infected children from Madrid, Spain.Patients from the Madrid cohort of HIV-infected children (1993-2009) with available pol sequences or infected samples stored at the Spanish HIV-1 BioBank were selected. Specimens were used to perform new pol sequences when not available. HIV-1 variants were characterized by phylogenetic analysis. Resistance mutations were identified according to the International AIDS Society-USA list (2009).In 198 patients, pol sequences were recovered from routine resistance testing (n = 98) or newly performed using stored plasma, lymphocytes or DNA (n = 100). Patients were mostly Europeans (90%), with moderate to severe AIDS symptoms (65%), on ART (85%) when the specimen was sequenced and infected by subtype B (90%). Among the 19 HIV-1 non-B variants found, 58% were recombinants (8CRF02_AG, 1CRF08_BC, 1CRF12_BF and 1CRF13_cpx) and the rest were 'pure' non-B subtypes (1A2, 2C, 2D, 1F1, 1G and 1H). Transmitted drug resistance (TDR) mutations were detected in 13% of naive children; 4%, 7% and 10% for protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs), respectively. Global resistance prevalence was higher (66%) among ART-exposed children; 37% for PIs, 54% for NRTIs and 35% for NNRTIs.HIV-1 non-B variants infected 10% of the cohort during 1993-2009. Resistant viruses were present in 26.5% and 66% of naive and pretreated children, respectively. Our data suggest that TDR prevalence in children could be higher than that reported in adults in Spain. The provided data will help to improve clinical management of HIV-infected children in Spain. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|